Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geovax Labs
(NQ:
GOVX
)
2.440
-0.030 (-1.21%)
Streaming Delayed Price
Updated: 3:23 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Geovax Labs
< Previous
1
2
3
4
5
6
Next >
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
April 04, 2024
Presentation Made During the 24th Annual World Vaccine Congress
Via
TheNewswire.com
Exposures
COVID-19
GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress
March 28, 2024
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Present at the 36th Annual Roth Conference
March 12, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the 36th Annual Roth Conference
March 08, 2024
Via
Investor Brand Network
Exposures
COVID-19
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
March 06, 2024
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines
Via
NewMediaWire
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
February 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
February 22, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
February 22, 2024
GeoVax to Host Conference Call at 4:30 PM ET
Via
TheNewswire.com
GeoVax to Present at the 2024 BIO CEO & Investor Conference
February 19, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the 2024 BIO CEO & Investor Conference
February 19, 2024
ATLANTA, GA - (NewMediaWire) - February 19, 2024 - Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today...
Via
TheNewswire.com
GeoVax Announces Multiple Patent Issuances and Allowances
February 13, 2024
Intellectual Property Assets Strengthened for Cancer Immunotherapy Program
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
February 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
February 06, 2024
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
Via
TheNewswire.com
Exposures
COVID-19
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
January 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
January 29, 2024
ATLANTA, GA - (NewMediaWire) - January 29, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
Via
TheNewswire.com
GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
January 08, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Announces Gedeptin Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
January 04, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Announces Issuance of Malaria Vaccine Patent
January 03, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox
December 19, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress
November 30, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Participate in Upcoming December Investor Events
November 29, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
November 28, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
November 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 8, 2023
October 31, 2023
GeoVax to Host Conference Call at 4:30 PM ET
Via
NewMediaWire
GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine
October 30, 2023
Designed to Protect Immunocompromised Patients Against Severe COVID-19
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Participate in Upcoming November Investor and Industry Events
October 25, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities
October 24, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Earnings
Intellectual Property
Exposures
COVID-19
Financial
Intellectual Property
GeoVax Receives Notice of Allowance for Marburg Vaccine Patent
October 09, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
GeoVax Receives Notice of Allowance for HIV Vaccine Patent
October 05, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.